Familial Cancer and the BRCA1 Gene in the Jewish Community of Greater Washington

Forms and Documents

Document Name	Status

No forms / supporting documents in this ICR. Check IC Document Collections.

IC Document Collections

IC ID	Document Title	Status
7320	Familial Cancer and the BRCA1 Gene in the Jewish Community of Greater Washington	Migrated

ICR Details

OMB Control No: 0925-0428	ICR Reference No: 199604-0925-001
Status: Historical Inactive	Previous ICR Reference No: 199601-0925-001
Agency/Subagency: HHS/NIH	Agency Tracking No:
Title: Familial Cancer and the BRCA1 Gene in the Jewish Community of Greater Washington
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Withdrawn	Conclusion Date: 05/21/1996
	Date Received in OIRA: 04/10/1996
Terms of Clearance: NIH withdraws this package due to the collection of information being complete.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date		12/31/1996	05/31/1996
Responses	0	0	7,700
Time Burden (Hours)	0	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: The proposed data collection is integral to a medical research study of the BRCA1 gene. Recently an unexpectedly high frequency of a particular mutation in the BRCA1 gene was detected in Jewish individuals. We propose to study approximately 5,000 Jewish individuals from Greater Washington by collecting a small blood sample and a brief questionnaire that concentrates on family history of cancer. This study will refine the estimate of how commonly certain BRCA1 mutations occur in this population and will estimate the risk of cancer in those who carry a mutation. These estimates are essential....

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
Familial Cancer and the BRCA1 Gene in the Jewish Community of Greater Washington

---

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 04/10/1996

---